Randy Moss's Bile-Duct Cancer: Symptoms and Diagnosis

What he said

Speaking on Instagram Live in December 2024, and reported by the Associated Press, Randy Moss said a cancerous mass had been found in his bile duct, between his pancreas and liver.

He gave the sequence. A stent was placed in his liver on Thanksgiving. About a week later he had a six-hour operation to remove the cancer, which he named as a Whipple procedure. He was in hospital for six days, and said he would go on to have radiation and chemotherapy. He was 47.

That is his account and this page keeps to it. It does not describe his pathology, his stage, or his health since.

Where these cancers start

Bile is made in the liver, helps digest fat, and travels to the small intestine through a network of ducts. Cancer can begin anywhere along that network, and NCI divides it by location because the location decides almost everything else.

Intrahepatic tumors start in the ducts inside the liver. Perihilar tumors, also called Klatskin tumors, start where the right and left hepatic ducts leave the liver and join. Distal tumors start in the common bile duct as it runs down toward the small intestine.

The proportions are uneven. About 50% are perihilar, 40% distal, and 10% intrahepatic. A mass sitting between the pancreas and the liver, as Moss described, is in the distal territory. Our page on cholangiocarcinoma explained covers the anatomy in more detail.

NCI calls this cancer extremely rare, and adds a caution. The true incidence is unknown, because an accurate diagnosis is hard to make.

What it does first

Distal and perihilar tumors block the duct. NCI lists what a blockage produces:

• Jaundice, meaning yellowing of the skin and the whites of the eyes
• Weight loss
• Abdominal pain
• Fever
• Itching, sometimes intense and all over

Intrahepatic tumors behave differently. NCI notes they can be relatively quiet and hard to tell apart from cancer that has spread to the liver from somewhere else.

How it is worked up

NCI lists liver function tests and other blood work, abdominal ultrasound, CT, MRI, and MRCP — magnetic resonance cholangiopancreatography, an MRI setting that maps the bile ducts specifically.

Those tests show how far the tumor reaches and whether it has spread. If the person is fit for surgery and the tumor looks removable, surgery follows. The final stage comes from examining what was taken out.

Stents come up early. When jaundice is severe, a stent or a drain can relieve the blockage. NCI notes that draining before surgery is controversial. The evidence of benefit is inconsistent, and there is concern about more complications afterward. A stent treats the blockage. It does not treat the cancer. Our page on biliary drains and stents covers living with one.

What surgery involves

NCI is unambiguous that complete removal with clear margins is the only chance of cure.

It is also unambiguous about how often that is possible. For tumors starting in the distal bile duct, total resection can be achieved in 25% to 30%. The rate is lower for tumors further up. The obstacles are anatomical. These ducts run alongside major blood vessels. The tumor also spreads along the duct wall further than it looks.

For a distal tumor with nearby lymph nodes involved, NCI says a wide removal may be warranted. That is the Whipple procedure. It takes out the head of the pancreas, part of the small intestine, the gallbladder, and the bile duct, then reconnects what is left. NCI does not give a five-year survival figure for resected distal disease; the 20% to 50% five-year range it cites belongs to perihilar tumours removed with an aggressive liver resection.

Operations for bile duct cancer are large. NCI cites a historical cohort with an operative mortality of roughly 10% and about a 40% risk of the disease returning. Our page on recovering from Whipple surgery covers what the months afterward involve.

Treatment after surgery

The evidence here is genuinely mixed, and NCI says so.

The UK BILCAP trial took 447 people who had a complete removal and assigned them at random to eight cycles of capecitabine or to watching and waiting. Follow-up ran a median of 106 months. Median overall survival was 49.6 months with the drug and 36.1 months without. That gap did not reach statistical significance. Median recurrence-free survival was 24.3 months against 17.4 months, and the gain sat mostly in the first two years.

NCI's summary of the wider picture: retrospective series suggest adjuvant chemotherapy after complete resection may help, but randomized trials have not consistently shown a survival benefit.

What raises the risk

NCI lists a short set. Primary sclerosing cholangitis, a long-running inflammatory disease of the bile ducts. Chronic ulcerative colitis. Choledochal cysts, which are abnormal swellings of the duct usually present from birth. And infection with the liver fluke Clonorchis sinensis.

Most people who develop bile duct cancer have none of them. There is no screening test for adults at average risk. People with one of those conditions should follow the surveillance plan their specialist sets.

When to get checked

Jaundice is the symptom that matters most here, and it is the one that gets people diagnosed.

See a doctor the same week for:

• Yellowing of the skin or the whites of the eyes
• Dark urine together with pale, chalky stools
• Itching all over with no rash

Seek urgent care, the same day, for jaundice with fever or shaking chills. That combination can mean an infected blocked duct.

Also worth reporting: lasting pain in the upper right abdomen, and unintended weight loss. Most turn out to be gallstones, hepatitis, or a drug effect. They still need a cause found. Our page on jaundice as a sign of cancer covers the range of causes.

What this story cannot tell you

• It does not reveal his exact pathology, stage, or full treatment plan, and this page does not infer them.
• Needing a stent does not mean cancer. It means a duct was blocked.
• The survival ranges above apply to people whose tumors could be completely removed. Most cannot be.
• Bile duct symptoms overlap heavily with benign conditions, which is part of why this cancer is often found late.

Sources

• Associated Press via NFL.com, Pro Football Hall of Famer Randy Moss announces cancer diagnosis, six-hour surgery — https://www.nfl.com/news/hall-of-fame-wr-randy-moss-announces-battle-with-cancer-outside-of-bile-duct
• NCI PDQ, Bile Duct Cancer (Cholangiocarcinoma) Treatment (Health Professional Version) — https://www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq
• NCI PDQ, Bile Duct Cancer (Cholangiocarcinoma) Treatment (Patient Version) — https://www.cancer.gov/types/liver/patient/bile-duct-treatment-pdq

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.